Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CA | P42336 | 2/20 | 0.39 |
| ▸ | LIMK1 | P53667 | 2/20 | 0.39 |
| ▸ | PIM1 | P11309 | 3/20 | 0.37 |
| ▸ | PIM2 | Q9P1W9 | 3/20 | 0.37 |
| ▸ | PIM3 | Q86V86 | 3/20 | 0.37 |
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.36 |
| ▸ | HTR2C | P28335 | 1/20 | 0.35 |
| ▸ | TNKS | O95271 | 2/20 | 0.35 |
| ▸ | TNKS2 | Q9H2K2 | 2/20 | 0.35 |
| ▸ | TSPO | P30536 | 1/20 | 0.34 |
| ▸ | PRKCI | P41743 | 2/20 | 0.33 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.32 |
| ▸ | ACP1 | P24666 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17030425 | 0.98 | PIK3CA (0.40) | PIK3CALIMK1PIM1PIM2PIM3 | |
| SCHEMBL16905707 | 0.92 | PIK3CA (0.44) | PIK3CALIMK1PIM1PIM2HRH4 | |
| SCHEMBL17087618 | 0.92 | KDM4E (0.36) | PIK3CALIMK1PIM1PIM2PIM3 | |
| SCHEMBL18273146 | 0.91 | ACP1 (0.39) | PIK3CAHRH4ACP1 | |
| SCHEMBL17087602 | 0.91 | PIK3CA (0.34) | PIK3CALIMK1PIM1PIM2PIM3 | |
| SCHEMBL17030462 | 0.90 | PIK3CA (0.39) | PIK3CAHRH4HTR2CTNKSTNKS2 | |
| SCHEMBL16905647 | 0.90 | ATM (0.40) | PIK3CALIMK1HRH4HTR2CTNKS | |
| SCHEMBL23072406 | 0.90 | PIK3CA (0.36) | PIK3CALIMK1PIM1PIM2PIM3 | |
| SCHEMBL20670231 | 0.89 | LIMK1 (0.41) | PIK3CALIMK1PIM1PIM2PIM3 | |
| SCHEMBL20068440 | 0.89 | PIK3CA (0.38) | PIK3CAPIM1PIM2PIM3HRH4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220115600-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2022-04-14 | — | — | US | disclosed |
| EP-2910555-B1 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORP (US) | 2019-03-27 | — | — | EP | disclosed |
| US-9502656-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2016-11-22 | — | — | US | disclosed |
| US-9502656-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2016-11-22 | — | — | US | disclosed |
| US-20150243893-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2015-08-27 | — | — | US | disclosed |
| US-20150243893-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2015-08-27 | — | — | US | disclosed |
| EP-2910555-A1 | Organic electroluminescent materials and devices | Universal Display Corporation (US) | 2015-08-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220115600-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING ORGANIC LIGHT-EMITTING DEVICE | CYP1A1, AOX1, CYP2E1 | PIK3CA 4346/4885LIMK1 261/4885PIM1 1169/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.